The Prevent Severe COVID-19 (PRESECO) Study
Clinical trial NCT04600895 · COMPLETED
Trial details
- NCT number
- NCT04600895
- Sponsor
- Appili Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-30
- Primary completion
- 2021-10-20
- Enrollment
- 1187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.